Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The Board of Directors of Supergenics ("Supergenics" or "Company") wishes to announce that the resolutions as set out in the Notice of Extraordinary General Meeting of the Company was duly passed by the shareholders of Supergenics by way of show of hands through Zoom online meeting platform from the Broadcast Venue.
Voting Results
1. Ordinary Resolution 1
Description
Proposed private placement of up to 26,000,000 new ordinary shares in Supergenics, representing approximately 27.96% of the existing total number of issued shares of the Company at an issue price to be determined and announced later ("Proposed Private Placement")
Shareholder’s Action
For Voting
Voted
For
Against
No. of Shareholders
3
0
No. of Shares
2,000,000
0
% of Voted Shares
100.0000
0.0000
Result
Accepted
2. Ordinary Resolution 2
Description
Proposed diversification of the principal activities of Supergenics Group to include the provision of administrative health care services, operating of medical laboratories and development of regenerative treatment products for medical treatment and wellness ("Proposed Diversification")